Airway Occlusion Pressure (P0.1) Guided Pressure Support Ventilation Versus Conventional Management in Weaning Window Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorTanta University

About this trial

This study aims to determine whether Airway Occlusion Pressure (P0.1) Guided Pressure Support Ventilation is superior to conventional management for patients in weaning windows.

Eligibility criteria

Qualifiers

Mechanically ventilated adult patients ≥ 21 years.

Patients on pressure support ventilation for at least 24 hours and clinically determined to be in the weaning window (transition between assisted ventilation and spontaneous ventilation) with improving respiratory status.

Hemodynamically stable [mean arterial pressure (MAP) ≥60 mmHg].

All patients will be required to have light sedation with a Richmond Agitation-Sedation Scale (RASS) score between -1 and 0 to allow reliable assessment of respiratory drive.

Disqualifiers

Patients with neuromuscular disorders affecting respiratory drive

Glasgow Coma Scale (GCS) score below 8

Cervical spinal cord injury

Receipt of neuromuscular blockers within the previous 24 hours

Trial design

Treatments tested in this trial

  • Pressure support ventilation protocol
  • Airway occlusion pressure (P0.1)-guided pressure support ventilation (PSV)

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators